Apoptosis Induction and Growth Suppression by U19/Eaf2 is Mediated Through Its ELL-binding Domain
Overview
Affiliations
Background: U19/Eaf2 is an androgen-response gene and its downregulation is frequently observed in advanced human prostate cancer. U19/Eaf2 interacts with ELL, a fusion partner of MLL in the (11;19) (q23;p13.1) translocation in acute myeloid leukemia. U19/Eaf2 overexpression induces apoptosis and suppresses xenograft tumor growth.
Methods: Transfection and colony formation were used to assay for apoptosis and growth suppression of various U19/Eaf2 mutants. Co-immunoprecipitation was performed to test the interaction between the U19/Eaf2 constructs and ELL.
Results: The region of U19/Eaf2 essential for apoptosis and growth suppression was mapped to amino acids 68-113. This region was necessary and sufficient for binding ELL. Co-expression of U19/Eaf2 and ELL in 293 cells lead to significant increase in cell death and growth suppression.
Conclusions: These observations argue that the interaction with ELL is essential for the induction of apoptosis and growth suppression by U19/Eaf2.
EAF2: a tumor suppressor gene with multi-aspect functions.
Ji W, Cui C, Wang Y Front Pharmacol. 2024; 15:1440511.
PMID: 39588149 PMC: 11586179. DOI: 10.3389/fphar.2024.1440511.
Overview of research on fusion genes in prostate cancer.
Song C, Chen H Transl Cancer Res. 2022; 9(3):1998-2011.
PMID: 35117547 PMC: 8798317. DOI: 10.21037/tcr.2020.01.34.
Guo W, Keener A, Jing Y, Cai L, Ai J, Zhang J Prostate. 2015; 75(9):976-87.
PMID: 25808853 PMC: 4424106. DOI: 10.1002/pros.22982.
Cai L, Wang D, Fisher A, Wang Z Biochem Biophys Res Commun. 2014; 447(2):292-8.
PMID: 24727455 PMC: 4038965. DOI: 10.1016/j.bbrc.2014.03.138.
Qiao Z, Wang D, Hahn J, Ai J, Wang Z Prostate. 2013; 74(2):113-20.
PMID: 24272884 PMC: 4827099. DOI: 10.1002/pros.22729.